Prostate Cancer Vaccine ‘Promising’
Increasing survival rates by over 20% after three years in men with advanced prostate cancer which is no longer responding to hormonal treatments is a good result. Not dramatic or miraculous, but good.
Prostate cancer is the most common form of cancer in Australian men. As many men die from prostate cancer as women from breast cancer – about one every three hours – but prostate cancer receives only ten percent as much research and publicity funding.
Consequently community understanding of prostate cancer screening and testing procedures and their importance is much lower than for breast or cervical cancer.
One of the hopes is that results from this early research into using the body’s own immune system to fight prostate cancer may be transferable to other forms of cancer, and at earlier stages.